116 related articles for article (PubMed ID: 11906549)
21. ras and c-myc oncoproteins during tumor progression in the uterine cervix.
Nair SA; Nair MB; Jayaprakash PG; Rajalekshmy TN; Nair MK; Pillai MR
Tumori; 1998; 84(5):583-8. PubMed ID: 9862521
[TBL] [Abstract][Full Text] [Related]
22. Amplification of the c-myc proto-oncogene in cervical carcinoma.
Baker VV; Hatch KD; Shingleton HM
J Surg Oncol; 1988 Dec; 39(4):225-8. PubMed ID: 3193767
[TBL] [Abstract][Full Text] [Related]
23. Amplification and overexpression of TP63 and MYC as biomarkers for transition of cervical intraepithelial neoplasia to cervical cancer.
Zhu D; Jiang XH; Jiang YH; Ding WC; Zhang CL; Shen H; Wang XL; Ma D; Hu Z; Wang H
Int J Gynecol Cancer; 2014 May; 24(4):643-8. PubMed ID: 24662128
[TBL] [Abstract][Full Text] [Related]
24. Clinical significance of human telomerase RNA gene (hTERC) amplification in cervical squamous cell lesions detected by fluorescence in situ hybridization.
Jin Y; Li JP; He D; Tang LY; Zee CS; Guo SZ; Zhou J; Chen JN; Shao CK
Asian Pac J Cancer Prev; 2011; 12(5):1167-71. PubMed ID: 21875260
[TBL] [Abstract][Full Text] [Related]
25. EGFR protein expression and gene amplification in squamous intraepithelial lesions and squamous cell carcinomas of the cervix.
Li Q; Tang Y; Cheng X; Ji J; Zhang J; Zhou X
Int J Clin Exp Pathol; 2014; 7(2):733-41. PubMed ID: 24551297
[TBL] [Abstract][Full Text] [Related]
26. Bcl-2 expression in preinvasive and invasive cervical lesions.
Ozalp SS; Yalcin OT; Tanir HM; Dundar E; Yildirim S
Eur J Gynaecol Oncol; 2002; 23(5):419-22. PubMed ID: 12440815
[TBL] [Abstract][Full Text] [Related]
27. Up-regulation of VEGF, c-fms and COX-2 expression correlates with severity of cervical cancer precursor (CIN) lesions and invasive disease.
Hammes LS; Tekmal RR; Naud P; Edelweiss MI; Kirma N; Valente PT; Syrjänen KJ; Cunha-Filho JS
Gynecol Oncol; 2008 Sep; 110(3):445-51. PubMed ID: 18565574
[TBL] [Abstract][Full Text] [Related]
28. HPV16 E6*II gene expression in intraepithelial cervical lesions as an indicator of neoplastic grade: a pilot study.
Pastuszak-Lewandoska D; Bartosińska-Dyc A; Migdalska-Sęk M; Czarnecka KH; Nawrot E; Domańska D; Szyłło K; Brzeziańska E
Med Oncol; 2014 Mar; 31(3):842. PubMed ID: 24436016
[TBL] [Abstract][Full Text] [Related]
29. C-myc mutation detected by polymerase chain reaction--heteroduplex in cervical cancer.
Wong YF; Rogers MS; Cheung TH; Yim SF; Chang AM
Gynecol Obstet Invest; 1997; 44(2):136-40. PubMed ID: 9286730
[TBL] [Abstract][Full Text] [Related]
30. [Detection of TERC gene amplification by fluorescence in-situ hybridization in cervical intraepithelial lesions].
YUAN YL; HE CN; XU MT; XU CQ; SUN YN; ZHAO HF; CHEN C
Zhonghua Bing Li Xue Za Zhi; 2011 Mar; 40(3):182-6. PubMed ID: 21575390
[TBL] [Abstract][Full Text] [Related]
31. High correlation between molecular alterations of the c-myc oncogene and carcinoma of the uterine cervix.
Ocadiz R; Sauceda R; Cruz M; Graef AM; Gariglio P
Cancer Res; 1987 Aug; 47(15):4173-7. PubMed ID: 3300961
[TBL] [Abstract][Full Text] [Related]
32. Genomic amplification of the human telomerase gene (hTERC) associated with human papillomavirus is related to the progression of uterine cervical dysplasia to invasive cancer.
Liu H; Liu S; Wang H; Xie X; Chen X; Zhang X; Zhang Y
Diagn Pathol; 2012 Oct; 7():147. PubMed ID: 23107094
[TBL] [Abstract][Full Text] [Related]
33. Clinical significance of hTERC and C-Myc genes amplification in a group of Egyptian patients with cancer cervix.
Eid MM; Nossair HM; Ismael MT; Amira G; Hosney MM; Abdul Rahman R
Gulf J Oncolog; 2011 Jul; (10):18-26. PubMed ID: 21724525
[TBL] [Abstract][Full Text] [Related]
34. Gene amplification and immunohistochemical expression of ERBB2 and EGFR in cervical carcinogenesis. Correlation with cell-cycle markers and HPV presence.
Conesa-Zamora P; Torres-Moreno D; Isaac MA; Pérez-Guillermo M
Exp Mol Pathol; 2013 Oct; 95(2):151-5. PubMed ID: 23827764
[TBL] [Abstract][Full Text] [Related]
35. Detection of hTERC and c-MYC genes in cervical epithelial exfoliated cells for cervical cancer screening.
Li T; Tang L; Bian D; Jia Y; Huang X; Zhang X
Int J Mol Med; 2014 May; 33(5):1289-97. PubMed ID: 24626956
[TBL] [Abstract][Full Text] [Related]
36. [Evaluation of genomic amplification of the human telomerase RNA component gene in the screening of cervical lesions].
Jiang J; Tu Z; Zhang G; Li JR; Zhao LJ; Zhao C; Cui SH; Li XP; Chen Z; Wei LH
Zhonghua Fu Chan Ke Za Zhi; 2008 Nov; 43(11):849-53. PubMed ID: 19087570
[TBL] [Abstract][Full Text] [Related]
37. Molecular analysis of the PI3K-AKT pathway in uterine cervical neoplasia: frequent PIK3CA amplification and AKT phosphorylation.
Bertelsen BI; Steine SJ; Sandvei R; Molven A; Laerum OD
Int J Cancer; 2006 Apr; 118(8):1877-83. PubMed ID: 16287065
[TBL] [Abstract][Full Text] [Related]
38. [Cell oncogene expression in normal, metaplastic, dysplastic epithelium and squamous cell carcinoma of the uterine cervix].
Petrov SV; Mazurenko NN; Sukhova NM; Moroz IP; Katsenel'son VM; Raĭkhlin NT; Kiselev FL
Arkh Patol; 1994; 56(4):22-31. PubMed ID: 7848100
[TBL] [Abstract][Full Text] [Related]
39. Human papillomavirus DNA integration and messenger RNA transcription in cervical low- and high-risk squamous intraepithelial lesions in Austrian women.
Manavi M; Hudelist G; Fink-Retter A; Gschwantler-Kaulich D; Pischinger K; Czerwenka K
Int J Gynecol Cancer; 2008; 18(2):285-94. PubMed ID: 17587315
[TBL] [Abstract][Full Text] [Related]
40. Genomic imbalances in 70 snap-frozen cervical squamous intraepithelial lesions: associations with lesion grade, state of the HPV16 E2 gene and clinical outcome.
Alazawi W; Pett M; Strauss S; Moseley R; Gray J; Stanley M; Coleman N
Br J Cancer; 2004 Dec; 91(12):2063-70. PubMed ID: 15545968
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]